跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DAPTOMYCIN FOR INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DAPTOMYCIN FOR INJECTION
Authorized
STANDARD
DAPTOMYCIN FOR INJECTION
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
27dbc18bc07631e9
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
27dbc18bc07631e9
Drug Approval Canada Name
DAPTOMYCIN FOR INJECTION
Product Name
DAPTOMYCIN FOR INJECTION
Status
Marketed
Status Date
2020-10-27
Original Market Date
2020-10-27
Din
02490838
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:12.28.12
Atc Original
J01XX09 DAPTOMYCIN
Atc Name
j 01 xx 09
Aig Number
0152298001
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
DAPTOMYCIN
500 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
27dbc18bc07631e9
Type
Standard
Back to Health Canada Approvals